CIK 0001088856 · Large accelerated filer
CORCEPT THERAPEUTICS INC
Sign in to watch- Ticker
- CORT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 770487658
- Phone
- 650.688.8803
- Business address
- 101 REDWOOD SHORES PARKWAY, REDWOOD CITY, CA, 94065
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $41,067,988
- in 15 filings, $36.6M under 10b5-1 plans
Net −$41,067,988. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-06-04 | Robb Gary Charles Chief Business Officer | Option exercise · Stock option (right to buy) | −14,000 | 36,037 | ||
| 2024-06-03 | Robb Gary Charles Chief Business Officer | Shares withheld for taxes | −724 | $30.17 | $22K | 19,479 |
| 2024-06-03 | Robb Gary Charles Chief Business Officer | Grant or award | +1,818 | $31.30 | $57K | 21,297 |
| 2024-06-03 | Robb Gary Charles Chief Business Officer | Grant or award | +1,818 | 23,115 | ||
| 2024-06-03 | Lyon Joseph Douglas See Remarks | Option exercise 10b5-1 | +5,000 | $11.35 | $57K | 12,314 |
| 2024-06-03 | Lyon Joseph Douglas See Remarks | Sale 10b5-1 | −5,000 | $30.18 | $151K | 7,314 |
| 2024-06-03 | Lyon Joseph Douglas See Remarks | Shares withheld for taxes 10b5-1 | −488 | $30.17 | $15K | 6,826 |
| 2024-06-03 | Lyon Joseph Douglas See Remarks | Grant or award 10b5-1 | +1,232 | $31.30 | $39K | 8,058 |
| 2024-06-03 | Lyon Joseph Douglas See Remarks | Grant or award 10b5-1 | +1,232 | 9,290 | ||
| 2024-06-03 | Lyon Joseph Douglas See Remarks | Option exercise · Stock option (right to buy) 10b5-1 | −5,000 | 14,167 | ||
| 2024-06-03 | Swisher Daniel N JR Director | Option exercise 10b5-1 | +2,200 | $5.86 | $13K | 2,200 |
| 2024-06-03 | Swisher Daniel N JR Director | Sale 10b5-1 | −2,200 | $30.21 | $66K | 0 |
| 2024-06-03 | Swisher Daniel N JR Director | Option exercise · Stock option (right to buy) 10b5-1 | −2,200 | 2,350 | ||
| 2024-06-03 | Maduck Sean See Remarks | Shares withheld for taxes | −823 | $30.17 | $25K | 84,399 |
| 2024-06-03 | Guyer William Chief Development Officer | Option exercise 10b5-1 | +10,000 | $19.26 | $193K | 16,039 |
| 2024-06-03 | Guyer William Chief Development Officer | Sale 10b5-1 | −10,000 | $32.00 | $320K | 6,039 |
| 2024-06-03 | Guyer William Chief Development Officer | Option exercise · Stock option (right to buy) 10b5-1 | −10,000 | 50,000 | ||
| 2024-06-03 | Mokari Atabak Chief Financial Officer | Shares withheld for taxes | −571 | $30.17 | $17K | 8,965 |
| 2024-06-03 | Mokari Atabak Chief Financial Officer | Grant or award | +1,448 | $31.30 | $45K | 10,413 |
| 2024-06-03 | Mokari Atabak Chief Financial Officer | Grant or award | +1,448 | 11,861 |
Page 38 of 61 · 1,220 trades